Comparison Between Antigen and Allelic HLA Mismatches, and the Risk of Acute Rejection in Kidney Transplant Recipients

Documenti analoghi

• Clinical Applicability of 2‐Field High‐Resolution and Extended HLA‐Allele Typing in Deceased Donor Kidney Allocation
  di: Zhan Lim, et al.
  Pubblicazione: (2024)
• Peptide Sharing Between CMV and Mismatched HLA Class I Peptides Promotes Early T‐Cell‐Mediated Rejection After Kidney Transplantation
  di: Emma T. M. Peereboom, et al.
  Pubblicazione: (2024)
• Acute Rejection With DSA ‐Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04 ‐Mismatch Successfully Stabilised With Daratumumab
  di: Laura Knödl, et al.
  Pubblicazione: (2026)
• Letter to the Editor in Response to Paper “Peptide Sharing Between CMV and Mismatched HLA Class I Peptides Promotes Early T‐ Cell‐Mediated Rejection After Kidney Transplantation”
  di: Jip Jonker, et al.
  Pubblicazione: (2025)
• A Novel HLA‐A*32 Variant Allele, HLA‐A*32:174 Detected in a Kidney Transplant Recipient
  di: Juan López‐Pérez, et al.
  Pubblicazione: (2025)